严重意外性低体温患者入院次日测定的生物标志物神经元特异性烯醇化酶与S100b对不良预后具有高预测价值
该研究连续纳入核心温度<32°C的严重意外性低体温患者,接受主动复温和/或体外生命支持(ECLS,包括体外循环和/或体外膜氧合)治疗。入院次日检测NSE与S100b,30天后随访,以脑功能分级(CPC)3-5分定义为不良神经预后。共34例患者,29例(85%)为心脏骤停复苏后,27例(79%)启动ECLS;入院次日3例(9%)死亡、1例(3%)清醒,故在30例昏迷和/或镇静患者中分析标志物。NSE与S100b预测30天死亡的AUC分别为0.93和0.88,预测不良神经预后的AUC分别为0.88和0.87。作者认为,在入院次日仍昏迷的严重意外性低体温患者中,NSE与S100b似乎是死亡和30天不良神经预后的可靠预测指标。
要点
- 严重意外性低体温定义为核心温度<32°C,连续纳入的患者接受主动复暖和/或ECLS(体外循环和/或ECMO)治疗。
- 共34例患者,29例(85%)为心脏骤停复苏后,27例(79%)启动ECLS;入院次日3例(9%)死亡、1例(3%)清醒。
- NSE与S100b在入院次日仍昏迷和/或镇静的30例患者中检测,预测30天死亡AUC分别为0.93和0.88。
- NSE与S100b预测30天不良神经预后(CPC 3-5分)的AUC分别为0.88和0.87。
- 作者认为,在入院次日仍昏迷的严重意外性低体温患者中,NSE与S100b似乎是死亡和不良神经预后的可靠预测指标。
适用人群与场景
- 连续纳入的严重意外性低体温患者,定义为核心温度<32°C。
- 患者接受主动复暖和/或体外生命支持(ECLS),包括体外循环(ECC)和/或体外膜氧合(ECMO)。
- 入院次日仍昏迷和/或镇静的患者(30例)进行NSE与S100b分析。
诊断标准与关键阈值
- 严重意外性低体温:核心温度<32°C。
- 不良神经预后:30天随访时脑功能分级(CPC)评分为3-5分。
处置流程与药物剂量
- 患者接受主动复暖和/或ECLS(体外循环和/或ECMO)治疗。
- 入院次日采血分析NSE与S100b。
- 30天后随访评估CPC评分。
研究设计与关键结果
- 研究类型为连续纳入患者的队列研究,共34例严重意外性低体温患者,29例(85%)为心脏骤停复苏后,27例(79%)启动ECLS。
- 入院次日3例(9%)死亡、1例(3%)清醒,NSE与S100b在30例昏迷和/或镇静患者中分析。
- NSE预测30天死亡的AUC为0.93,S100b预测30天死亡的AUC为0.88。
- NSE预测30天不良神经预后(CPC 3-5分)的AUC为0.88,S100b的AUC为0.87。
证据类型、等级与局限
- 证据类型:连续纳入患者的队列研究。
- 局限:样本量小(共34例);原文未报告其他局限性。
对床旁实践的改变
- 在严重意外性低体温(核心温度<32°C)患者入院次日仍昏迷和/或镇静时,NSE与S100b似乎可用于预测30天死亡和不良神经预后。
- 作者认为,在入院次日仍昏迷的严重意外性低体温患者中,NSE与S100b似乎是死亡和不良神经预后的可靠预测指标。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
AIM: The aim of the present study was to assess the ability of the biomarkers neuron-specific enolase (NSE) and S100 calcium-binding protein b (S100b) to predict mortality and poor neurologic outcome after 30days in patients admitted with severe accidental hypothermia.
METHODS: Consecutive patients with severe accidental hypothermia, defined as a core temperature <32°C, were included. Patients were treated with active rewarming and/or extracorporeal life support (ECLS) using extra corporeal circulation (ECC) and/or extra corporeal membrane oxygenation (ECMO). The day following admission blood was analyzed for NSE and S100b. Follow-up was conducted after 30days and poor neurologic outcome was defined as a Cerebral Performance Category (CPC) score of 3-5. The predictive value of NSE and S100b was assessed as the area under the receiver-operating characteristics curve (AUC).
RESULTS: A total of 34 patients were admitted with a diagnosis of severe accidental hypothermia and 29 (85%) were resuscitated from cardiac arrest. ECLS was initiated in 27 (79%) of patients. The day following admission three (9%) patients had died and one (3%) patient was awake, and accordingly, NSE and S100b were analyzed in 30 unconscious and/or sedated patients. NSE and S100b achieved AUCs of 0.93 and 0.88, respectively, for prediction of 30day mortality and AUCs of 0.88 and 0.87, respectively, for prediction of poor neurologic outcome.
CONCLUSIONS: In patients remaining unconscious the day following admission for severe accidental hypothermia, the biomarkers NSE and S100b appear to be solid predictors of mortality and poor neurologic outcome after 30days.
参考来源
- Wiberg S, Kjaergaard J, Kjærgaard B, et al. The biomarkers neuron-specific enolase and S100b measured the day following admission for severe accidental hypothermia have high predictive values for poor outcome. Resuscitation. 2017. PMID: 29017847. doi:10.1016/j.resuscitation.2017.10.006
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。